CLASS II Device recall · Reported 5 Nov 2014 · FDA Enforcement Report

Dimension Vista¿ HbA1c recalled by Siemens Healthcare Diagnostics

Siemens Healthcare Diagnostics is recalling Dimension Vista¿ HbA1c, distributed nationwide in the US. The recall was initiated on 14 Aug 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codescatalog #K3105A, material #10470481, All in-date lots
Quantity recalled20043

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0127-2015
FDA event ID
69334
Recalling firm
Siemens Healthcare Diagnostics, Newark, DE
Classification
Class II
Status
Terminated
Recall initiated
14 Aug 2014
FDA classified
24 Oct 2014
Reported
5 Nov 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

14 Aug 2014Recall initiated by company
24 Oct 2014Classified by FDA+71 days
5 Nov 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

In March, Siemens Healthcare Diagnostics issued an Urgent Medical Device Correction for decreased recovery of patient samples with the Dimension Vista® CSA & CSAE Flex® reagent cartridges when whole blood samples are run from Small Sample Containers (SSC). Siemens has confirmed that when whole blood samples are run from SSC, HbA1c values may exhibit a percent bias ranging from - 8.2% t

Product as listed by the FDA

Dimension Vista¿ HbA1c

Where it was distributed

Worldwide Distribution: US (nationwide) and country of: Canada.

Nationwide

Questions about this recall

Why was it recalled?

In March, Siemens Healthcare Diagnostics issued an Urgent Medical Device Correction for decreased recovery of patient samples with the Dimension Vista® CSA & CSAE Flex® reagent cartridges when whole blood samples are run from Small Sample Containers (SSC). Siemens has confirmed that when whole blood samples are run from SSC, HbA1c values may exhibit a percent bias ranging from - 8.2% t

Which lots are affected?

catalog #K3105A, material #10470481, All in-date lots

Where was it sold?

Worldwide Distribution: US (nationwide) and country of: Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Other Medical Devices recalls

All 13,778